Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study by Souza, WM, Amorim, MR, Sesti-Costa, R, Coimbra, LD, Brunetti, NS, Toledo-Teixeira, DA, de Souza, GF, Muraro, SP, Parise, PL, Barbosa, PP, Bispo-dos-Santos, K, Mofatto, LS, Simeoni, CL, Claro, IM, Duarte, ASS, Coletti, TM, Zangirolami, AB, Costa-Lima, C, Gomes, ABSP, Buscaratti, LI, Sales, FC, Costa, VA, Franco, LAM, Candido, DS, Pybus, OG, de Jesus, JG, Silva, CAM, Ramundo, MS, Ferreira, GM, Pinho, MC, Souza, LM, Rocha, EC, Andrade, PS, Crispim, MAE, Maktura, GC, Manuli, ER, Santos, MNN, Camilo, CC, Angerami, RN, Moretti, ML, Spilki, FR, Arns, CW, Addas-Carvalho, M, Benites, BD, Vinolo, MAR, Mori, MAS, Gaburo, N, Dye, C, Marques-Souza, H, Marques, RE

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil by Faria, NR, Mellan, TA, Whittaker, C, Claro, IM, Candido, DDS, Mishra, S, Crispim, MAE, Sales, FCS, Hawryluk, I, McCrone, JT, Hulswit, RJG, Franco, LAM, Ramundo, MS, de Jesus, JG, Andrade, PS, Coletti, TM, Ferreira, GM, Silva, CAM, Manuli, ER, Pereira, RHM, Peixoto, PS, Kraemer, MUG, Gaburo, N, Camilo, CDC, Hoeltgebaum, H, Souza, WM, Rocha, EC, de Souza, LM, de Pinho, MC, Araujo, LJT, Malta, FSV, de Lima, AB, Silva, JDP, Zauli, DAG, Ferreira, ACDS, Schnekenberg, RP, Laydon, DJ, Walker, PGT, Schlüter, HM, Dos Santos, ALP, Vidal, MS, Del Caro, VS, Filho, RMF, Dos Santos, HM, Aguiar, RS, Proença-Modena, JL, Nelson, B, Hay, JA, Dye, C, Pybus, O